There continues to be a need for the development of novel therapeutic strategies to attenuate acute lung injury in clinical medicine. Heat shock protein-70 (HSP-70) is an intracellular protein that confers protection against diverse forms of cellular injury. The central hypothesis of this research application is that increased expression of HSP-70 in distal respiratory epithelium will protect against acute lung injury. To directly test this hypothesis, the applicant will generate transgenic mice expressing HSP-70 in a lung specific manner. Lung specific HSP-70 expression will be achieved by placing the human HSP-70 cDNA under the control of promoter elements that direct expression of heterologous proteins to specific subsets of distal respiratory epithelium. The applicant will determine: 1) the effects of increased HSP-70 expression on lung development and function, 2) if increased expression of HSP-70 protects against acute lung injury, 3) the spatial determinants of protection, and 4) the effects of increased HSP-70 on injury-associated lung inflammation and surfactant dysfunction. Long term, these data will form the basis for future studies directed towards the use of HSP-70 expression as a therapeutic strategy to attenuate acute lung injury in the clinical setting. The principal investigator is currently an Assistant Professor of Pediatrics in the Division of Critical Care Medicine, Department of Pediatrics. The Mentored Clinical Scientist Development Award will allow the principal investigator to continue his development as a clinician-scientist. The research environment presents an extraordinary opportunity because of the many successful independent investigators in the fields of pulmonary biology and lung injury at this institution. The experimental design in this application includes challenging goals. The information gained will contribute positively to knowledge regarding protective strategies against acute lung injury.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Clinical Investigator Award (CIA) (K08)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-Y (M1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Cincinnati Children's Hospital Medical Center
United States
Zip Code
Wheeler, Derek S; Dunsmore, Katherine E; Wong, Hector R (2003) Intracellular delivery of HSP70 using HIV-1 Tat protein transduction domain. Biochem Biophys Res Commun 301:54-9
Zingarelli, Basilia; Sheehan, Maeve; Wong, Hector R (2003) Nuclear factor-kappaB as a therapeutic target in critical care medicine. Crit Care Med 31:S105-11
Grossman, Bruce J; Shanley, Thomas P; Denenberg, Alvin G et al. (2002) Phosphatase inhibition leads to activation of IkappaB kinase in murine macrophages. Biochem Biophys Res Commun 297:1264-9
Chen, Philip C; Wheeler, Derek S; Malhotra, Vivek et al. (2002) A green tea-derived polyphenol, epigallocatechin-3-gallate, inhibits IkappaB kinase activation and IL-8 gene expression in respiratory epithelium. Inflammation 26:233-41
Malhotra, Vivek; Kooy, Neil W; Denenberg, Alvin G et al. (2002) Ablation of the heat shock factor-1 increases susceptibility to hyperoxia-mediated cellular injury. Exp Lung Res 28:609-22
Malhotra, Vivek; Wong, Hector R (2002) Interactions between the heat shock response and the nuclear factor-kappa B signaling pathway. Crit Care Med 30:S89-95
Wong, Hector R; Odoms, Kelli K; Denenberg, Alvin G et al. (2002) Hyperoxia prolongs tumor necrosis factor-alpha-mediated activation of NF-kappaB: role of IkappaB kinase. Shock 17:274-9
Grossman, Bruce J; Shanley, Thomas P; Odoms, Kelli et al. (2002) Temporal and mechanistic effects of heat shock on LPS-mediated degradation of IkappaBalpha in macrophages. Inflammation 26:129-37
Sheehan, Maeve; Wong, Hector R; Hake, Paul W et al. (2002) Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents. Mol Pharmacol 61:953-63
Pritts, Timothy A; Hungness, Eric S; Hershko, Dan D et al. (2002) Proteasome inhibitors induce heat shock response and increase IL-6 expression in human intestinal epithelial cells. Am J Physiol Regul Integr Comp Physiol 282:R1016-26

Showing the most recent 10 out of 20 publications